{"id":"W4200333351","doi":"10.1016/s1470-2045(25)00522-4","title":"Correction to Lancet Oncol 2024; 25: 1038–52","year":2025,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Grail; Program for Creating STart-ups from Advanced Research and Technology; UCLH Biomedical Research Centre; Novartis; Merck Sharp and Dohme; American Association for Cancer Research; Servier; Basilea Pharmaceutica; Medical Research Council; Celgene; Johnson and Johnson; AstraZeneca; Genentech; Ipsen; Vifor Pharma; PharmaMar; Deutsche Krebshilfe; Bayer; Astellas Pharma; MedImmune; Daiichi-Sankyo; National Institutes of Health; CRUK Lung Cancer Centre of Excellence; Rosetrees Trust; Cancer Research UK; Janssen Pharmaceuticals; Breast Cancer Research Foundation; Canadian Cancer Society; Center for Cancer Research; National Institute for Health and Care Research; Clovis Oncology; Astex Pharmaceuticals; Harvard University; Entertainment Industry Foundation; AbbVie; National Cancer Institute; Gilead Sciences; Pfizer; Baxter International; Merck; GlaxoSmithKline; Boehringer Ingelheim; Amgen; American Society of Clinical Oncology; Bristol-Myers Squibb; Deutsche Forschungsgemeinschaft; Roche; Astellas Pharma US","keywords":"Medicine; Family medicine","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005477937,0.0001373002,0.0006392261,0.0001084587,0.0001217466,0.0000141771,0.0002385311,0.0001146215,0.001248318],"category_scores_gemma":[0.000250823,0.00009718769,0.00008214218,0.000356709,0.00008492253,0.0000406414,0.00009819751,0.0005344594,0.0003303398],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006186663,"about_ca_system_score_gemma":0.0006465872,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002321809,"about_ca_topic_score_gemma":0.0007646471,"domain_scores_codex":[0.9988215,0.000153048,0.0002402693,0.0002702755,0.0001246526,0.0003902632],"domain_scores_gemma":[0.9988797,0.0003651802,0.00006399665,0.0005241426,0.00007331459,0.00009369838],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001370111,0.00006520853,0.00727114,0.00005199361,0.00009039057,0.00003018566,0.0003753765,0.00003987445,0.002320281,0.0007172677,0.9037976,0.08387059],"study_design_scores_gemma":[0.002920506,0.0005702613,0.05314692,0.00006960134,0.00008082839,0.00004979618,0.0002129051,0.0004033188,0.0005980162,0.0001729397,0.9416822,0.0000927509],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"empirical","genre_scores_codex":[0.09771144,0.0004557396,0.000573508,0.08724792,0.009600664,0.0009058187,0.00002088486,0.0001686662,0.8033153],"genre_scores_gemma":[0.6328479,0.0006698735,0.001667762,0.1662207,0.00582255,0.0003422537,0.000056921,0.00003410199,0.1923379],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.6109774,"threshold_uncertainty_score":0.9996647,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04504243712373093,"score_gpt":0.3746384579841051,"score_spread":0.3295960208603741,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}